A kinetic study of the oxidation effects of amphotericin B on human low-density lipoproteins.
FEBS Lett
; 465(1): 83-6, 2000 Jan 07.
Article
en En
| MEDLINE
| ID: mdl-10620711
The UV-visible results of this kinetic study show that amphothericin B as Fungizone is a much stronger oxidant than CuSO(4), itself a powerful oxidant of low-density lipoprotein (LDL). Amphotericin B as AmBisome alone has no oxidizing effect on LDL while a mixture of both AmBisome and CuSO(4) induces an important potentialization of the LDL oxidation. These results allow us to believe that the high toxicity of amphotericin B is related to its capacity to modify and to weaken the structure of LDL. In addition, differential scanning calorimetry experiments show that the oxidative modifications of LDL by CuSO(4) or by amphotericin B proceed through different mechanisms.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Anfotericina B
/
Lipoproteínas LDL
Límite:
Humans
Idioma:
En
Revista:
FEBS Lett
Año:
2000
Tipo del documento:
Article
País de afiliación:
Canadá
Pais de publicación:
Reino Unido